{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320012677760.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.2215/cjn.05000516"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/01277230-201702000-00017"}}],"dc:title":[{"@value":"Minimal Change Disease"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>Minimal change disease (MCD) is a major cause of idiopathic nephrotic syndrome (NS), characterized by intense proteinuria leading to edema and intravascular volume depletion. In adults, it accounts for approximately 15% of patients with idiopathic NS, reaching a much higher percentage at younger ages, up to 70%–90% in children >1 year of age. In the pediatric setting, a renal biopsy is usually not performed if presentation is typical and the patient responds to therapy with oral prednisone at conventional doses. Therefore, in this setting steroid-sensitive NS can be considered synonymous with MCD. The pathologic hallmark of disease is absence of visible alterations by light microscopy and effacement of foot processes by electron microscopy. Although the cause is unknown and it is likely that different subgroups of disease recognize a different pathogenesis, immunologic dysregulation and modifications of the podocyte are thought to synergize in altering the integrity of the glomerular basement membrane and therefore determining proteinuria. The mainstay of therapy is prednisone, but steroid-sensitive forms frequently relapse and this leads to a percentage of patients requiring second-line steroid-sparing immunosuppression. The outcome is variable, but forms of MCD that respond to steroids usually do not lead to chronic renal damage, whereas forms that are unresponsive to steroids may subsequently reveal themselves as FSGS. However, in a substantial number of patients the disease is recurrent and requires long-term immunosuppression, with significant morbidity because of side effects. Recent therapeutic advances, such as the use of anti-CD20 antibodies, have provided long-term remission off-therapy and suggest new hypotheses for disease pathogenesis.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320012677763","@type":"Researcher","foaf:name":[{"@value":"Marina Vivarelli"}],"jpcoar:affiliationName":[{"@value":"Division of Nephrology and Dialysis, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; and"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320012677761","@type":"Researcher","foaf:name":[{"@value":"Laura Massella"}],"jpcoar:affiliationName":[{"@value":"Division of Nephrology and Dialysis, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; and"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320012677760","@type":"Researcher","foaf:name":[{"@value":"Barbara Ruggiero"}],"jpcoar:affiliationName":[{"@value":"Clinical Research Center for Rare Diseases “Aldo e Cele Daccò”, IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Ranica, Bergamo, Italy"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320012677762","@type":"Researcher","foaf:name":[{"@value":"Francesco Emma"}],"jpcoar:affiliationName":[{"@value":"Division of Nephrology and Dialysis, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; and"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"15559041"},{"@type":"EISSN","@value":"1555905X"}],"prism:publicationName":[{"@value":"Clinical Journal of the American Society of Nephrology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2016-12-09","prism:volume":"12","prism:number":"2","prism:startingPage":"332","prism:endingPage":"345"},"reviewed":"false","url":[{"@id":"https://journals.lww.com/01277230-201702000-00017"}],"createdAt":"2016-12-10","modifiedAt":"2023-08-13","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050003824925970560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360016862127247744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282228233344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Novel Mouse Model of Idiopathic Nephrotic Syndrome Induced by Immunization with the Podocyte Protein Crb2"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282437290880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430173607552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025431090850816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effective calcineurin inhibitor treatment in adult-onset steroid-resistant nephrotic syndrome with a novel splice donor site variant of TRPC6: a case report"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617828985856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302864783808384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Steroid-resistant minimal change nephrotic syndrome associated with thymoma treated effectively with rituximab following thymectomy and cyclosporine: a case report"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092826367104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Metformin ameliorates the severity of experimental Alport syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118835021696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Urinary and plasma proteomics to discover biomarkers for diagnosing between diabetic nephropathy and minimal change nephrotic syndrome or membranous nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340529891712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Exploring the significance of interleukin-33/ST2 axis in minimal change disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340704275968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Japanese clinical practice patterns of rituximab treatment for minimal change disease in adults 2021: A web-based questionnaire survey of certified nephrologists"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588380595361664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Estimating baseline creatinine levels based on the kidney parenchymal volume"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588381045243008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of proteinuria at relapse on shear wave velocity assessed using ultrasound elastography in children with idiopathic nephrotic syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657643609472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Idiopathic nephrotic syndrome in children"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869855576721920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Activation of the inflammasome and pyroptosis cascade in podocytes of patients with minimal change disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390019058250048256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Minimal Change Nephrotic Syndrome Secondary to Methotrexate-associated Hodgkin Lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1390023571556582656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Simultaneous Presentation of Minimal Change Disease and Tubulointerstitial Nephritis Associated with Primary Sjögren's Syndrome and Hashimoto's Thyroiditis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390025419436442624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Coronavirus Disease 2019-associated Minimal Change Disease: Transient Improvement Does Not Preclude the Need for Standard Therapy in a Case Report and Review of the Literature"}]},{"@id":"https://cir.nii.ac.jp/crid/1391131406305601024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/2050588892107103104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A case of minimal change nephrotic syndrome with pregnancy"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.2215/cjn.05000516"},{"@type":"CROSSREF","@value":"10.1007/s40620-022-01279-z_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1681/asn.2022010070_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1007/s00467-022-05783-z_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.5811-25_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1007/s10157-023-02449-4_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1007/s13730-024-00935-6_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1016/j.autrev.2020.102671_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1186/s12882-024-03485-2_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.5499-20_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1038/s41598-021-86109-1_references_DOI_ASHkdgrNdJbxfuLuT0pPoVAnnN5"},{"@type":"CROSSREF","@value":"10.1007/s13730-020-00568-5_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1016/j.bbrep.2021.101102_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1038/s41598-023-45678-z_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0299053_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.4747-24_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1007/s10157-024-02526-2_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1007/s10396-024-01455-7_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.2572-23_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1093/ckj/sfae216_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1016/s0140-6736(18)30536-1_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0228337_references_DOI_AfiAnafYLqDiC5lGbvnK5wMSnte"}]}